The oncological excellence centers in Tübingen-Stuttgart (CCC-TS) and Ulm (CCCU) have been confirmed as the joint location „NCT-SüdWest“ for the expanded National Center for Tumor Diseases (NCT). The expanded NCT, comprising six locations, will receive annual funding of 98 million euros, making it the largest financial network support for national cancer research in the history of the Federal Republic.
The NCT-SüdWest successfully underwent a two-year strategy phase, and its main goal, along with all NCT locations, is to support clinical cancer research in Germany and provide faster access to innovative cancer therapies for patients. Patient involvement as research partners is a key concept, and each NCT location will have patient councils, allowing patients to contribute to the research process from the outset. The NCT-SüdWest is highly regarded for its development of targeted molecular therapies, with a focus on leukemias, lymphomas, breast cancer, and pancreatic cancer.